Bharat Serums And Vaccines Limited, a amalgamated public limited company, was established on 29 April 1971 in Mumbai, Maharashtra, India. Engaging in biotechnology within the manufacturing sector, it holds CIN: U24230MH1971PLC015134. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹21.95 Cr and a paid-up capital of ₹9.01 Cr.
Formerly known as Gautam Laboratories Limited, Gautam Laboratories Private Limited. It upholds a compliant status. Its leadership includes Shweta Jalan (Director), Abhijit Mangalmoy Mukherjee (Director), Chirag Ashokbhai Mehta (Cfo). Past directors included Kamalesh Sarangi, Prakash Dharshibhai Shah, Balasubramaniam Venkatasubramaniam Kollengode. It holds no open charges and ₹427.21 Cr settled loans. Its latest AGM occurred on 27 August 2021, with the balance sheet filed on 31 March 2021. It is based at 17Th Floor, Hoechst House Nariman Point, Mumbai, Mumbai, Maharashtra, 400021.
U24230MH1971PLC015134
015134
29 April 1971
₹21.95 Cr
₹9.01 Cr
Roc Mumbai
Unlisted
Amalgamated
Explore comprehensive insights into Bharat Serums And Vaccines Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Shweta Jalan | Director | 07 Feb 2020 | Current |
| Abhijit Mangalmoy Mukherjee | Director | 07 Feb 2020 | Current |
| Chirag Ashokbhai Mehta | Cfo | 15 Jul 2020 | Current |
| Sanjiv Hari Navangul | Managing Director | 07 Feb 2020 | Current |
| Bharat Vinod Daftary | Director | 05 May 1992 | Current |
| Jayesh Tulsidas Merchant | Director | 07 Feb 2020 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Alternate Director | 30 Mar 2010 | Past |
| Pramod Abcsdd | Director | 30 Mar 2009 | Past |
| Pramod Abcsdd | Ceo(Kmp) | 27 Feb 2017 | Past |
| Pramod Abcsdd | Additional Director | 26 Aug 2020 | Past |
| Pramod Abcsdd | Director | 16 Apr 2008 | Past |
| Pramod Abcsdd | Whole-Time Director | 20 Oct 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bharat Serums And Vaccines Limited, for the financial year ended 2021, experienced Minor drop in revenue, with a 0.11% decrease. The company also saw a substantial improvement in profitability, with a 86.62% increase in profit. The company's net worth Soared by an impressive increase of 17.42%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Bharat Serums And Vaccines had a promoter holding of 76.87% and a public holding of 23.13%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹4,272,129,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 16 Aug 2017 | Others | ₹36.80 Cr | Satisfied |
| 21 Nov 2014 | Others | ₹35.00 Cr | Satisfied |
| 22 Mar 2013 | Export-Import Bank Of India | ₹20.00 Cr | Satisfied |
| 01 Mar 2013 | Export-Import Bank Of India | ₹35.00 Cr | Satisfied |
| 24 Jan 2012 | Export Import Bank Of India | ₹35.00 Cr | Satisfied |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Bharat Serums And Vaccines, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Bharat Serums And Vaccines, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bharat Serums And Vaccines's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge registered on 16 Jul 2009 via Charge ID 10174588 with Bank Of Baroda was fully satisfied on 18 Sep 2021. was documented.
A charge registered on 21 Nov 2014 via Charge ID 10534842 with Others was fully satisfied on 03 Sep 2021. was recorded as a recent event.
Progress on Bharat Serums And Vaccines Limited last Annual general meeting of members was held on 27 Aug 2021 as per latest MCA records. was documented.
A charge registered on 16 Aug 2017 via Charge ID 100121272 with Others was fully satisfied on 23 Aug 2021. was recorded as a recent event.
Bharat Serums And Vaccines Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was recorded as a recent event.
Anupama Diwakar Pai was appointed as a Company Secretary was appointed as a Company Secretary on 14 Nov 2020 & has been associated with this company since 5 years 2 months . was recorded as a recent event.
Kotak PE and OrbiMed together hold 23% stake in BSV. The rest of the stake is with the Daftary family. .
Promoters of Bharat Serums and Vaccines (BSV) are reconsidering their plan to exit their 50-year old business for around Rs 3,500 crore. .
They are up against domestic pharma companies Dr Reddy's Labs, Mankind & Goldman Sachs which have also made offers..
When you're trying to sell your company for $500 million and you ask PE firms like Carlyle and Advent to buy a controlling stake, but they're like "nah, we want to be in charge." So you're like "fine, take control, just give us the money." But then you remember that time when Mylan, Baring Private Equity, and Cadila Healthcare wanted to buy you, but you were like "nah, we'll just go public." And now you're like "oops, maybe we should have taken that deal." #humblebrag #shouldhavegonepublic #PEproblems.
The two funds together hold a 23% stake and the remainder is with the Daftary family..
The private equity investor could offload a major part of its holding through the IPO, said one of the persons, who did not wish to be identified..
The CIN of Bharat Serums And Vaccines Limited is U24230MH1971PLC015134.
Bharat Serums And Vaccines Limited is headquartered at 17Th Floor, Hoechst House Nariman Point, Mumbai, Mumbai, Maharashtra, 400021.
Bharat Serums And Vaccines Limited was incorporated on 29 April 1971.
The current directors of Bharat Serums And Vaccines Limited are
The primary industry of Bharat Serums And Vaccines Limited is Manufacturing.
Bharat Serums And Vaccines Limited is unlisted.
The authorized capital of Bharat Serums And Vaccines Limited is ₹21.95 Cr, and the paid-up capital is ₹9.01 Cr.
The compliance status of Bharat Serums And Vaccines Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX